Relationship between reduced nicotinamide adenine dinucleotide phosphate oxidase subunit p22phox gene polymorphism and obstructive sleep apnea-hypopnea syndrome in the Chinese Han population

Chinese Medical Journal

Volumn 122, Issue 12, 2009, Pages 1369-1374

  Liu, Hui Guo ^a   Liu, Kui ^a   Zhou, Yan Ning ^a   Xu, Yong Jian ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Obstructive sleep apnea syndrome; P22phox gene; Polymorphism; Reduced nicotinamide adenine dinucleotide phosphate oxidase

Indexed keywords

CYSTEINE; MESSENGER RNA; SUPEROXIDE DISMUTASE; THREONINE;

ADULT; ANTHROPOMETRIC PARAMETERS; APNEA HYPOPNEA INDEX; ARTICLE; BLOOD SAMPLING; BODY MASS; CHINESE; COMPARATIVE STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME BLOOD LEVEL; GENE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NECK CIRCUMFERENCE; OXIDATIVE STRESS; OXYGEN SATURATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTE; POLYMERASE CHAIN REACTION; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE SUBUNIT P22PHOX GENE; RESPIRATORY TRACT PARAMETERS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SLEEP APNEA SYNDROME; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; BODY MASS INDEX; CHINA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NADPH OXIDASE; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SLEEP APNEA, OBSTRUCTIVE; WAIST-HIP RATIO; YOUNG ADULT;

EID: 68249138144     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.12.003     Document Type: Article

References (32)

1. Han F. Obstructive sleep apnea hypopnea syndrome: a proinflammatory disorder. Chin Med J 2007; 120: 1475-1476.
2. McCarthy MI. Susceptibility gene discovery for common metabolic and endocrine traits. J Mol Endocrinol 2002; 28: 1-17.
3. Selmi C, Montano N, Furlan R, Keen CL, Gershwin ME. Inflammation and oxidative stress in obstructive sleep apnea syndrome. Exp Biol Med 2007; 232: 1409-1413.
4. Jin HM, Xu QJ, Zhou PJ, Ding YD, Zhang Z, Yu PQ. Impaired gp-91phoxgene expression and dysfunction of peripheral blood neutrophils in patients maintaining hemodialysis. Chin Med J 2000; 113: 120-123.
5. Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier JL. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Phyiol Endocrinol Metab 2001; 280: E685-E694.
6. Lee HB, Yu MR, Yang Y, Jiang Z, Ha H. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol 2003; 14 (8 Suppl 3): S241-S245.
7. Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M. Polymorphism of the NADH/NADPH oxidase p22phox gene in patients with coronary artery disease. Circulation 1998; 97: 135-137.
8. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22: 667-689.
9. Hodgkinson AD, Millward BA, Demaine AG. Association of the p22phox component of NAD(P)H oxidase with susceptibility to diabetic nephropathy in patients with type 1 diabetes. Diabetes Care 2003 26: 3111-3115.
10. Kaparianos A, Sampsonas F, Karkoulias K, Spiropoulos K. Obstructive sleep apnoea syndrome and genes. Neth J Med 2006; 64: 280-289.
11. Thompson DB, Ravussin E, Bennett PH, Bogardus C. Structure and sequence variation at the human leptin receptor gene in lean and obese Pima Indians. Hum Mol Genet 1997; 6: 675-679.
12. Li C, Zhang XL, Liu H, Wang ZG, Yin KH. Association among plasma interleukin-18 levels, carotid intima-media thickness and severity of obstructive sleep apnea. Chin Med J 2009; 122: 24-29.
13. Redline S, Tosenson T, Tishler PV, Carskadon MA, Millman RP. Studies in the genetics of obstructive sleep apnea. Familial aggregation of symptoms associated with sleep-related breathing disturbances. Am Rev Respir Dis 1992; 145: 440-444.
14. Wasik M, Popko K, Gorska K, Stoklosa A, Plywaczewski R, Winiarska M, et al. Frequency of distribution of leptin receptor gene polymorphism in obstructive sleep apnea patients. Can J Physiol pharmacol 2007; 58: 551-561.
15. Xiao Y, Huang X, Qiu C, Zhu X, Liu Y. Angiotensin I-converting enzyme gene polymorphism in Chinese patients with obstructive sleep apnea syndrome. Chin Med J 1999; 112: 701-704.
16. Liu HG, Lin M, Xu YJ, Guan P, Zhang ZX. The relationship between tumor necrosis factor-alpha gene promoter polymorphism and obstructive sleep apnea-hypopnea. Chin J Tuberc Respir Dis (Chin) 2006; 29: 596-599.
17. Yue WH, Liu HG, Zhang JS, Zhang XH, Wang XP, Liu TQ, et al. Association study of serotonin transporter gene polymorphisms with obstructive sleep apnea syndrome in Chinese Han population. Sleep 2008; 31: 1535-1541.
18. Li A, Prasad A, Mincemoyer F. Relationship of the C242T p22phox gene polymorphism to angiographic coronary artery disease and endothelial function. Am J Med Genet 1999; 86: 57-61.
19. Saha N, Sanghera DK, Kamboh MI. The p22phox polymorphism C242T is not associated with CHD risk in Asian Indians and Chinese. Eur J Clin Invest 1999; 29: 999-1002.
20. Ito D, Murata M, Watanabe K, Yoshida T, Saito I, Tanahashi N, et al. C242T polymorphism of NADPH oxidase p22phox gene and ischemic cerebrovascular disease in the Japanese population. Stroke 2000; 31: 936-939.
21. Azumi H, Inoue N, Takeshita S, Rikitake Y, Kawashima S, Haysshi Y, et al. Expression of NADP/NADPH oxidase p22phox in human coronary arteries. Circulation 1999; 100: 1494-1498.
22. Guzik TJ, West NEJ, Black E, McDonald D, Ratnatunga C, Pillai R, et al. Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation 2000; 102: 1744-1747.
23. Wyche KE, Wang SS, Griendling KK, Dikalov SI, Austin H, Rao S, et al. C242T CYBA polymorphism of the NADPH oxidase is associated with reduced respiratory burst in human neutrophils. Hypertension 2004; 43: 1246-1251.
24. Kushida CA, Efron B, Guileminault C. Predictive morphometric model for the obstructive sleep apnea syndrome. Ann Intern Med 1997; 127: 581-587.
25. Gami AS, Caples SM, Somers VK. Obesity and obstructive sleep apnea. Endocrinol Metab Clin North Am 2003; 32: 869-894.
26. Ozata M, Mergen M, Oktenli C, Aydin A, Sanisoglu SY, Bolu E, et al. Increased oxidative stress and hypozincemia in male obesity. Clin Biochem 2002; 35: 627-631.
27. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-1761.
28. Couillard C, Ruel G, Archer WR, Pomerleau S, Bergeron J, Couture P, et al. Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. J Clin Endocrinol Metab 2005; 90: 6454-6459.
29. Keaney JF Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003; 23: 434-439.
30. Talior I, Tennenbaum T, Kuroki T, Eldar-Finkelman H. PKC-delta-dependent activation of oxidative stress in adipocytes of obese and insulin-resistant mice: role for NADPH oxidase. Am J Physiol Endocrinol Metab 2005; 288: 405-411.
31. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006; 440: 944-948.
32. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet 2003; 361: 598-604.